Previous Chief Executive Officer Jesper J. Lange’s pharmaceutical endeavor was bypassed when MC2 made executive modifications– in spite of an earlier strategy to elevate USD 90m to create a medicine.
发布者:BY ELLEN BIRKNER,转转请注明出处:https://robotalks.cn/mc2-ceo-exit-raises-questions-about-capital-raising-and-strategy-change/